Tumor-targeting drug displays promise for osteosarcoma patients
A study led by The University of Texas MD Anderson Cancer Center (Houston, TX, USA) has found a novel drug that could have the potential as a new therapeutic strategy for osteosarcoma.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.